Scholarlink

<p>The clinical management of <i>Nakaseomyces glabratus</i> is becoming increasingly difficult because of its intrinsic and acquired resistance to multiple antifungal drugs, particularly azoles. This situation highlights the urgent need for new antifungal agents. In this study, the antifungal efficacy and toxicity profile of an organometallic compound, named FE1, was evaluated in the in vivo model <i>Galleria mellonella</i> infection model. Larvae were inoculated with a standardized suspension of <i>N. glabratus</i> CBS138 and treated with FE1 or fluconazole at different concentrations (0.4, 4.0, and 20&#xa0;mg/kg). Survival and fungal burden (CFU/larva) were monitored at defined time points post-inoculation (24, 120 and 360&#xa0;h). The results obtained in this study show that the model of <i>N. glabratus</i> infection in <i>G. mellonella</i> is suitable to evaluate toxicity, antifungal efficacy and evolution of the infection in response to antifungal treatments. In this context, compound FE1 showed significant antifungal activity, superior to that of fluconazole in parameters evaluated, such as survival and fungal burden, while melanization was monitored as a qualitative visual indicator of infection progression. The dose-dependent response observed in both survival and CFU/larva reduction assays, together with the complete protection in the groups treated with 20&#xa0;mg/kg FE1 suggests a high therapeutic potential of this compound against <i>N. glabratus</i> infections.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluation of an Antifungal Agent Against Nakaseomyces Glabratus in the in Vivo Model Galleria Mellonella

  • 期刊论文

  • 发表日期：

    2026年1月9日

查看全文
  • Edson E. Maqueda-Cabrera,
  • Mayra Cuéllar-Cruz

摘要

The clinical management of Nakaseomyces glabratus is becoming increasingly difficult because of its intrinsic and acquired resistance to multiple antifungal drugs, particularly azoles. This situation highlights the urgent need for new antifungal agents. In this study, the antifungal efficacy and toxicity profile of an organometallic compound, named FE1, was evaluated in the in vivo model Galleria mellonella infection model. Larvae were inoculated with a standardized suspension of N. glabratus CBS138 and treated with FE1 or fluconazole at different concentrations (0.4, 4.0, and 20 mg/kg). Survival and fungal burden (CFU/larva) were monitored at defined time points post-inoculation (24, 120 and 360 h). The results obtained in this study show that the model of N. glabratus infection in G. mellonella is suitable to evaluate toxicity, antifungal efficacy and evolution of the infection in response to antifungal treatments. In this context, compound FE1 showed significant antifungal activity, superior to that of fluconazole in parameters evaluated, such as survival and fungal burden, while melanization was monitored as a qualitative visual indicator of infection progression. The dose-dependent response observed in both survival and CFU/larva reduction assays, together with the complete protection in the groups treated with 20 mg/kg FE1 suggests a high therapeutic potential of this compound against N. glabratus infections.